Board of Directors
-
John Manusu
Executive Chairman
Mr Manusu has over 20 years experience running biotechnology companies. Throughout this period he has been involved with start ups, turnarounds and mature organisations in the biotechnology space. Mr Manusu has undertaken a number of significant acquisitions and divestures, as well as raising over $100 million in public funding and $10 million of peer reviewed government R&D grants. Mr Manusu has a degree in Commerce and is a Fellow of the Financial Services Institute of Australasia. Mr Manusu has worked in the Australia and U.S. Biotechnology markets and is best described as a biotechnology entrepreneur. -
Dr Hari Nair
Managing Director and CEO
Dr Nair has a PhD in Medicine and Clinical Science from the Australian National University with his specialty in cardiovascular medicine and haematology. Dr Nair has received a number of awards from international organisations including being specially recognised for his role in coagulation research by the ACT government. He has run biotechnology companies in Australia and the US. Dr Nair has been heavily involved in mergers and acquisitions especially in the US and Europe and has US financial experience. Dr Nair has served on the boards of a number of international biotechnology companies and US state Commercialisation Boards. -
Iain Sorrell
Non-Executive Director
Mr Sorrell is based in the USA and has over 20 years experience in the Life Sciences arena. He has held senior sales and marketing positions in both corporate & start-up businesses both in Europe and the USA. In addition to his extensive knowledge of the separations industry he has also set-up and operated a successful import and distribution organization in the USA. He is a graduate of the University of Plymouth in Applied Biology. In addition to on-going consultative roles he is also actively involved on the board of trustees for non-profit organizations. He is best recognized for his ability to develop new markets and co-ordinate international distribution. -
David Roffe
Non-Executive Director
Member of Remuneration Committee, Non-executive Director since October 2011. Mr Roffe has over 31 years experience in the Biomedical and Computer Science fields spanning senior research, design and management positions in both the Public and Private sectors. He has degrees in Science and Engineering as well as Masters degrees in Biomedical Engineering and Business Administration. Mr Roffe’s passion is in mentoring innovation and organisation culture to deliver peak organisational performance. Independent peer reviews of his teams describe them as “Service Orientated and Professionally Excellent”. Mr Roffe has managed information systems departments in major Australian Public and Private hospital groups, where he has successfully commercialised a clinically focussed software suite. Mr Roffe was a Director of Gradipore, retiring in 1997, and was instrumental in Gradipore focusing on the PrIME process. Mr Roffe also has extensive knowledge in the rollout of complex medical software such as NuSep’s ProteoIQ software. -
Ward Wescott
Non-Executive Director
Chairman of Audit Committee, Non-executive Director since October 2011. Mr Wescott has over 30 years experience in finance markets, including over 20 years working for Citibank in Europe and the Asia-Pacific of which 9 years located in SE Asia. This gives him extensive contacts throughout Asian markets. In Australia, Mr Wescott was an early stage partner of Balmain Commercial where he was both transaction focussed and helped build Balmain into one of Australia's largest property finance organisations. Mr Wescott's Board Level experience consists of Country Head positions in Citibank and an Investment Bank Directorship in Singapore. At Balmain, Mr Wescott has been a Director for 16 years. This role continues. Member AICD. -
Andrew Goodall
Non-Executive Director
Non-executive Director since March 2012. Mr Goodall has been a significant shareholder in NuSep for a number of years. In addition he is also the Company’s largest shareholder. Mr Goodall brings a wealth of commercial experience to the Board. -
-
Tom Rowe
Company Secretary
Mr Rowe is a Corporate and Commercial Lawyer with a specialty in listed company secretarial practice. Mr Rowe holds a BA LLB (Hons) from the University of Adelaide and is an Associate of the Chartered Institute of Secretaries. He is the current Principal of Company Matters, a specialist provider of legal, governance and company secretarial services. Previously, he held the position of Legal Counsel and Company Secretary at CSR Ltd.
